Recent Transactions

20-Feb-24
Pending
$1.9 billion
United States flag
Target: 

Audacy Inc.

flag not available

Advising 1L Ad Hoc Group on the pre-packaged restructuring of Audacy, one of the largest multi-platform audio content and entertainment companies with 221 radio stations in 45 distinct markets

20-Feb-24
Pending
$185 million
Australia flag
Target: 

myHomecare Group

Australia flag
Acquiror: 
Australian Unity

Advising Australian Unity on its acquisition of myHomecare Group

14-Feb-24
Undisclosed
United Kingdom flag
Target: 

Huntswood CTC Limited

Acquiror: 
The Results Companies, LLC

Advised Huntswood CTC Limited, a business process and outsourcing company, on its sale to The Results Companies, LLC (“ResultsCX”), a global Customer Experience Management company backed by ChrysCapital

29-Jan-24
$4.8 billion
Bermuda flag
Target: 

Digicel Group

flag not available

Advised PGIM, Contrarian Capital Management, and GoldenTree Asset Management on the restructuring of Digicel Group, a communications and entertainment provider with operations in 25 Caribbean and Central American markets 

11-Jan-24
Pending
Undisclosed
Target: 

ElectraMeccanica

United States flag
Acquiror: 
Xos

Advising ElectraMeccanica on its all-stock merger with Xos, a leading manufacturer of battery electric commercial vehicles

09-Jan-24
Pending
Undisclosed
United States flag
Target: 

RedBuilt LLC

United States flag
Acquiror: 
Hampton Lumber

Advising Hampton Lumber, a sustainable lumber producer, on the acquisition of RedBuilt LLC, a leader in custom engineered structural systems

04-Dec-23
$530 million
United States flag
Target: 

FW Murphy Production Controls

United States flag
Acquiror: 
Dover Corporation

Advised Genisys Controls LLC on the sale of FW Murphy Production Controls, an instrumentation company that provides advanced monitoring and protection solutions used in sophisticated process applications, to Dover Corporation, a diversified global manufacturer and solutions provider

27-Sep-23
Undisclosed
United States flag
Target: 

Slayback Pharma LLC

United States flag
Acquiror: 
Azurity Pharmaceuticals

Advised Azurity Pharmaceuticals, a pharmaceutical company specializing in the provision of innovative medicines to overlooked patients, on the acquisition of Slayback Pharma LLC ("Slayback"), a company focused on complex generic and specialty pharmaceutical products

19-Sep-23
$60 million
United States flag
Target: 

Williams Industrial Services Group

United States flag
Acquiror: 
EnergySolutions

Advised Williams Industrial Services Group, (NYSE: WLMS), a maintenance & construction services provider to the commercial nuclear power and heavy industry markets, on its Section 363 sale to EnergySolutions, a global provider of nuclear, energy and industrial services

10-Aug-23
Undisclosed
United Kingdom flag
Target: 

Clinigen Ltd’s portfolio of Established Medicines

United Kingdom flag
Acquiror: 
CNX Therapeutics

Advised Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of a portfolio of Established Medicines to CNX Therapeutics, a UK-based European pharma company owned by Inflexion Partners

08-Aug-23
Pending
Undisclosed
Spain flag
Target: 

Farmalider Group

Spain flag
Acquiror: 
MCH

Advising the shareholders of Grupo Farmalider, a B2B Spanish pharmaceutical company focused on contract manufacturing, innovation and development of products based on generics, on the sale of an undisclosed stake to local private equity MCH

21-Jul-23
Undisclosed
France flag
Target: 

Synfonium / Qwant / Shadow

France flag
Acquiror: 
Caisse des Dépôts et Consignations (CDC) / Banque des Territoires

Advised Banque des Territoires / Groupe Caisse des Dépôts (CDC), a French Public Institution, on the investment in the newly created platform Synfonium, incorporating Shadow, a cloud-based platform, and Qwant, a sovereign search engine. CDC will hold a 25% stake in Synfonium, while Octave Klaba and Miroslaw Klaba, the co-founders of OVHcloud, will hold the remaining 75%

13-Jul-23
$224 million
Target: 

Distribuidora Internacional Carmen SAU

United States flag
Acquiror: 
Diploma PLC

Advised Diploma PLC in the acquisition of  Distribuidora Internacional Carmen SAU (“DICSA”),  a market-leading distributor of fluid power solutions into the European aftermarket

21-Jun-23
Pending
Undisclosed
United States flag
Target: 

Jacobson/Gershwind Family

United States flag
Acquiror: 
MSC Industrial Direct Co.

Advising the Jacobson/Gershwind Family in connection with the elimination of MSC Industrial's Class B common stock, which included the conversion of each share of Class B common stock into the right to receive 1.225 shares of Class A common stock

01-Jun-23
Pending
Undisclosed
United States flag
Target: 

Interest in Joint Venture with CarepathRx Health System Solutions

United States flag
Acquiror: 
The Cigna Group

Advising Cigna on its investment in CarepathRx Health System Solutions, under Evernorth, Cigna’s health services subsidiary

01-Jun-23
$90.4 million
Canada flag
Target: 

PCAS Canada Inc.

Japan flag
Acquiror: 
DIC Corporation

Advised DIC Corporation, a Japanese specialty chemical company, on the acquisition of PCAS Canada Inc., a contract manufacturer of high-quality photoresist polymers, from PCAS SA, a French manufacturer of complex molecules for Life Sciences and Specialty Chemicals markets which is a majority-owned subsidiary of SK Capital-backed Seqens

27-Apr-23
$403 million
Netherlands flag
Target: 

Distrelec BV

United Kingdom flag
Acquiror: 
RS Group plc

Advised RS Group plc on the acquisiton of Distrelec, a high-service, digital-led distributor of industrial MRO and electronic products

25-Apr-23
Pending
Undisclosed
United Kingdom flag
Target: 

Kyowa Kirin International’s testosterone replacement therapy drug, Tostran®

United Kingdom flag
Acquiror: 
Advanz Pharma (UK)

Advising Kyowa Kirin International, a subsidiary of Kyowa Kirin Co., Ltd, a Japanese global specialty pharma company, on the divestiture of its testosterone replacement therapy drug, Tostran®, to Advanz Pharma, a privately-held, specialty pharmaceutical company

05-Apr-23
Pending
$185 million
Australia flag
Target: 

Calibre Group’s QuadR Business

Canada flag
Acquiror: 
WSP Global Inc.

Advising Calibre Group, an Australian diversified engineering group, on the sale of its Calibre QuadR business to WSP Global Inc., a leading global engineering and professional services firm

31-Mar-23
Pending
$306.6 - 319.2 million
United States flag
Target: 

HIS Company, Inc. (“Hisco”)

United States flag
Acquiror: 
Distribution Solutions Group, Inc.

Advising Hisco, a leading employee-owned distributor of specialty products serving high growth industrial technology applications, on its sale to Distribution Solutions Group, Inc. (Nasdaq: DSGR), a premier specialty distribution company providing high touch, value-added distribution solutions to the maintenance, repair & operations (MRO), original equipment manufacturer (OEM) and industrial technologies markets

29-Mar-23
Pending
Undisclosed
Sweden flag
Target: 

Scandinavian Enviro Systems AB

France flag
Acquiror: 
Antin Infrastructure Partners

Advising Enviro on the creation of the world’s first large-scale tire recycling group in a JV with Antin Infrastructure Partners, supported by Michelin

20-Mar-23
Pending
Undisclosed
Target: 

Clinigen Ltd’s Lamda Laboratories

Germany flag
Acquiror: 
Adragos Pharma

Advising Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of Lamda Laboratories, a European contract development business, to Adragos Pharma, a Munich-based pharmaceutical CDMO

07-Mar-23
Undisclosed
United Kingdom flag
Target: 

David Brown Santasalo

United States flag
Acquiror: 
Stellex Capital Management

Advised N4 Partners on the sale of David Brown Santasalo (DBS), UK based industrial gear manufacturer, to Stellex Capital Management

23-Jan-23
Pending
$200 million
United Kingdom flag
Target: 

Clinigen Ltd’s Proleukin

United States flag
Acquiror: 
Iovance Biotherapeutics

Advising Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of Proleukin (Interleukin-2 (Aldesleukin)), to Iovance Biotherapeutics, a late-stage biotechnology company developing novel T cell-based cancer immunotherapies

09-Jan-23
Undisclosed
Switzerland flag
Target: 

Schurter

Switzerland flag
Acquiror: 
Capvis

Advising Capvis, a leading European mid-market investor, on the acquisition of Schurter, a global provider of components for circuit protection, connectors, switches and EMC products

Pages

show all